Literature DB >> 19915153

Impact of adiponectin deficiency on pulmonary responses to acute ozone exposure in mice.

Ming Zhu1, Christopher Hug, David I Kasahara, Richard A Johnston, Alison S Williams, Norah G Verbout, Huiqing Si, Jordan Jastrab, Amit Srivastava, Erin S Williams, Barbara Ranscht, Stephanie A Shore.   

Abstract

Obese mice have increased responses to acute ozone (O(3)) exposure. T-cadherin is a binding protein for the high-molecular weight isoforms of adiponectin, an anti-inflammatory hormone that declines in obesity. The objective of the present study was to determine whether adiponectin affects pulmonary responses to O(3), and whether these effects are mediated through T-cadherin. We performed bronchoalveolar lavage (BAL) and measured pulmonary responsiveness to methacholine after acute air or O(3) exposure (2 ppm for 3 h) in adiponectin-deficient (Adipo(-/-)) or T-cadherin-deficient (T-Cad(-/-)) mice. O(3) increased pulmonary responses to methacholine and increased BAL neutrophils and protein to a greater extent in wild-type than in Adipo(-/-) mice, whereas T-cadherin deficiency had no effect. O(3)-induced increases in BAL IL-6 and keratinocyte-derived chemokine (KC), which contribute to O(3)-induced pulmonary neutrophilia, were also greater in wild-type than in Adipo(-/-) mice. In contrast, responses to O(3) were not altered by transgenic overexpression of adiponectin. To determine which adiponectin isoforms are present in the lung, Western blotting was performed. The hexameric isoform of adiponectin dominated in serum, whereas BAL was dominated by the high-molecular weight isoform of adiponectin. Interestingly, serum adiponectin was greater in T-Cad(-/-) versus wild-type mice, whereas BAL adiponectin was lower in T-Cad(-/-) versus wild-type mice, suggesting that T-cadherin may be important for transit of high-molecular weight adiponectin from the blood to the lung. Our results indicate that adiponectin deficiency inhibits pulmonary inflammation induced by acute O(3) exposure, and that T-cadherin does not mediate the effects of adiponectin responsible for these events.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19915153      PMCID: PMC2951879          DOI: 10.1165/rcmb.2009-0086OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  59 in total

1.  Increased pulmonary responses to acute ozone exposure in obese db/db mice.

Authors:  Frank L Lu; Richard A Johnston; Lesley Flynt; Todd A Theman; Raya D Terry; Igor N Schwartzman; Anna Lee; Stephanie A Shore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-12-22       Impact factor: 5.464

2.  Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies.

Authors:  Yukihiro Takemura; Noriyuki Ouchi; Rei Shibata; Tamar Aprahamian; Michael T Kirber; Ross S Summer; Shinji Kihara; Kenneth Walsh
Journal:  J Clin Invest       Date:  2007-01-25       Impact factor: 14.808

3.  Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice.

Authors:  Stephanie A Shore; Raya D Terry; Lesley Flynt; Aimin Xu; Christopher Hug
Journal:  J Allergy Clin Immunol       Date:  2006-05-30       Impact factor: 10.793

4.  Pulmonary responses to acute ozone exposure in fasted mice: effect of leptin administration.

Authors:  Richard A Johnston; Todd A Theman; Raya D Terry; Erin S Williams; Stephanie A Shore
Journal:  J Appl Physiol (1985)       Date:  2006-08-17

5.  Globular adiponectin activates nuclear factor-kappaB and activating protein-1 and enhances angiotensin II-induced proliferation in cardiac fibroblasts.

Authors:  Yoshiyuki Hattori; Sachiko Hattori; Kazumi Akimoto; Toshio Nishikimi; Kunihiro Suzuki; Hiroaki Matsuoka; Kikuo Kasai
Journal:  Diabetes       Date:  2007-03       Impact factor: 9.461

6.  Intrinsic and antigen-induced airway hyperresponsiveness are the result of diverse physiological mechanisms.

Authors:  Scott S Wagers; Hans C Haverkamp; Jason H T Bates; Ryan J Norton; John A Thompson-Figueroa; Michael J Sullivan; Charles G Irvin
Journal:  J Appl Physiol (1985)       Date:  2006-09-28

7.  Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment.

Authors:  Rei Shibata; Kaori Sato; Masahiro Kumada; Yasuhiro Izumiya; Mina Sonoda; Shinji Kihara; Noriyuki Ouchi; Kenneth Walsh
Journal:  Cardiovasc Res       Date:  2007-02-12       Impact factor: 10.787

8.  Adiponectin binds to chemokines via the globular head and modulates interactions between chemokines and heparan sulfates.

Authors:  Hiroaki Masaie; Kenji Oritani; Takafumi Yokota; Isao Takahashi; Takahiro Shirogane; Hidetoshi Ujiie; Michiko Ichii; Norimitsu Saitoh; Tetsuo Maeda; Rie Tanigawa; Kazumasa Oka; Yoshihiko Hoshida; Yoshiaki Tomiyama; Yuzuru Kanakura
Journal:  Exp Hematol       Date:  2007-06       Impact factor: 3.084

9.  Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells.

Authors:  Olorunseun Olatunji Ogunwobi; Ian L P Beales
Journal:  Regul Pept       Date:  2006-03-10

10.  Susceptibility to ozone-induced airway inflammation is associated with decreased levels of surfactant protein D.

Authors:  S Kierstein; F R Poulain; Y Cao; M Grous; R Mathias; G Kierstein; M F Beers; M Salmon; R A Panettieri; A Haczku
Journal:  Respir Res       Date:  2006-06-01
View more
  24 in total

1.  Low serum adiponectin predicts future risk for asthma in women.

Authors:  Akshay Sood; Clifford Qualls; Mark Schuyler; Bharat Thyagarajan; Michael W Steffes; Lewis J Smith; David R Jacobs
Journal:  Am J Respir Crit Care Med       Date:  2012-04-06       Impact factor: 21.405

Review 2.  Update in environmental and occupational medicine 2009.

Authors:  Victor C Van Hee; Joel D Kaufman; G R Scott Budinger; Gökhan M Mutlu
Journal:  Am J Respir Crit Care Med       Date:  2010-06-01       Impact factor: 21.405

Review 3.  Obesity: "priming" the lung for injury.

Authors:  Jason Konter; Elizabeth Baez; Ross S Summer
Journal:  Pulm Pharmacol Ther       Date:  2012-03-17       Impact factor: 3.410

4.  Relationship of adipokines with immune response and lung function in obese asthmatic and non-asthmatic women.

Authors:  Anne E Dixon; Scott E Johnson; Laurianne V Griffes; Danielle M Raymond; Ramona Ramdeo; Avigail Soloveichik; Benjamin T Suratt; Rubin I Cohen
Journal:  J Asthma       Date:  2011-10       Impact factor: 2.515

5.  Pulmonary inflammation induced by subacute ozone is augmented in adiponectin-deficient mice: role of IL-17A.

Authors:  David I Kasahara; Hye Y Kim; Alison S Williams; Norah G Verbout; Jennifer Tran; Huiqing Si; Allison P Wurmbrand; Jordan Jastrab; Christopher Hug; Dale T Umetsu; Stephanie A Shore
Journal:  J Immunol       Date:  2012-04-02       Impact factor: 5.422

6.  The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease.

Authors:  Bram van den Borst; Harry R Gosker; Annemarie Koster; Binbing Yu; Stephen B Kritchevsky; Yongmei Liu; Bernd Meibohm; Thomas B Rice; Michael Shlipak; Sachin Yende; Tamara B Harris; Annemie M W J Schols
Journal:  Am J Clin Nutr       Date:  2012-07-18       Impact factor: 7.045

7.  Adiponectin attenuates lipopolysaccharide-induced acute lung injury through suppression of endothelial cell activation.

Authors:  Jason M Konter; Jennifer L Parker; Elizabeth Baez; Stephanie Z Li; Barbara Ranscht; Martin Denzel; Frederic F Little; Kazuto Nakamura; Noriyuki Ouchi; Alan Fine; Kenneth Walsh; Ross S Summer
Journal:  J Immunol       Date:  2011-12-07       Impact factor: 5.422

Review 8.  Beyond BMI: Obesity and Lung Disease.

Authors:  Ubong Peters; Benjamin T Suratt; Jason H T Bates; Anne E Dixon
Journal:  Chest       Date:  2017-07-17       Impact factor: 9.410

Review 9.  Obesity, adipokines, and lung disease.

Authors:  Akshay Sood
Journal:  J Appl Physiol (1985)       Date:  2009-11-19

10.  Obesity and asthma: an inflammatory disease of adipose tissue not the airway.

Authors:  Olga Sideleva; Benjamin T Suratt; Kendall E Black; William G Tharp; Richard E Pratley; Patrick Forgione; Oliver Dienz; Charles G Irvin; Anne E Dixon
Journal:  Am J Respir Crit Care Med       Date:  2012-07-26       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.